U.S. Markets open in 3 hrs 49 mins
  • S&P Futures

    4,254.50
    -32.00 (-0.75%)
     
  • Dow Futures

    33,792.00
    -189.00 (-0.56%)
     
  • Nasdaq Futures

    13,401.00
    -122.25 (-0.90%)
     
  • Russell 2000 Futures

    1,983.20
    -18.50 (-0.92%)
     
  • Crude Oil

    89.45
    -1.05 (-1.16%)
     
  • Gold

    1,766.50
    -4.70 (-0.27%)
     
  • Silver

    19.11
    -0.35 (-1.79%)
     
  • EUR/USD

    1.0084
    -0.0008 (-0.08%)
     
  • 10-Yr Bond

    2.8800
    0.0000 (0.00%)
     
  • Vix

    20.50
    +0.60 (+3.02%)
     
  • GBP/USD

    1.1874
    -0.0058 (-0.49%)
     
  • USD/JPY

    136.5560
    +0.6940 (+0.51%)
     
  • BTC-USD

    21,778.70
    -1,701.41 (-7.25%)
     
  • CMC Crypto 200

    517.63
    -40.10 (-7.19%)
     
  • FTSE 100

    7,542.05
    +0.20 (+0.00%)
     
  • Nikkei 225

    28,930.33
    -11.81 (-0.04%)
     

2 of the Safest Stocks to Buy in a Recession

·4 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Shares of AbbVie (NYSE: ABBV) are up by about 13% this year, which is a lot better than the benchmark S&P 500 index, which has lost 20% over the same period. With lots of high-margin revenue from top-selling drugs, there's a good chance that AbbVie stock will remain a safe haven even if the U.S. economy plunges into a deep recession. The top-selling drug for AbbVie is Humira.